Narrative Review: The Promotion of Gabapentin: An Analysis of Internal Industry Documents

@article{Steinman2006NarrativeRT,
  title={Narrative Review: The Promotion of Gabapentin: An Analysis of Internal Industry Documents},
  author={M. Steinman and L. Bero and M. Chren and C. Landefeld},
  journal={Annals of Internal Medicine},
  year={2006},
  volume={145},
  pages={284-293}
}
Key Summary Points Industry promoted gabapentin for on- and off-label uses as part of a comprehensive marketing plan. Frequent prescribers of anticonvulsant agents, opinion leaders, and local champions of gabapentin were specially targeted for promotion. Gabapentin was promoted by using education and research, activities not typically recognized as promotional. Independent continuing medical education, peer-to-peer selling by physician speakers, industry-funded studies, and publications in the… Expand
Study of neurontin: titrate to effect, profile of safety (STEPS) trial: a narrative account of a gabapentin seeding trial.
Gabapentin for Off-Label Use: Evidence-Based or Cause for Concern?
The Rise and Fall of Gabapentin for Bipolar Disorder: A Case Study on Off-Label Pharmaceutical Diffusion
Between evidence and commerce – the case of sufentanil sublingual tablet systems
Gabapentin in the Treatment of Mental Illness: The Echo Chamber of the Case Series
The promotion of olanzapine in primary care: an examination of internal industry documents.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 34 REFERENCES
Treatment of chronic pain with antiepileptic drugs: a new era.
  • H. Hansen
  • Medicine
  • Southern medical journal
  • 1999
Gabapentin for Treatment of Pain and Tremor: A Large Case Series
Accepting commercial sponsorship
...
1
2
3
4
...